Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:28:01.603Z.
Calculation as of: 2026-10-06T21:28:01.603Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1f0f34e1a3c3db59aa089d09e3018975893bb9567e33ddb8ff6924431e0b2b95
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Pulse Biosciences, Inc.
Market Cap
$3.44B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.48B
Free Cash Flow Yield
N/A
TTM Avg
9.07%
3Y Avg
9.10%
5Y Avg
9.10%
Market Cap
$3.38B
Free Cash Flow Yield
5.16%
TTM Avg
3.81%
3Y Avg
3.52%
5Y Avg
3.52%
Market Cap
$3.36B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.52B
Free Cash Flow Yield
1.11%
TTM Avg
0.68%
3Y Avg
0.59%
5Y Avg
0.59%
Market Cap
$3.54B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.56B
Free Cash Flow Yield
4.64%
TTM Avg
3.79%
3Y Avg
2.70%
5Y Avg
2.46%
Market Cap
$3.57B
Free Cash Flow Yield
N/A
TTM Avg
6.75%
3Y Avg
6.75%
5Y Avg
6.75%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.44B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | N/A | 9.07% | 9.10% | 9.10% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 5.16% | 3.81% | 3.52% | 3.52% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 1.11% | 0.68% | 0.59% | 0.59% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | N/A | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 4.64% | 3.79% | 2.70% | 2.46% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | N/A | 6.75% | 6.75% | 6.75% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
